Wearing Off
Mostrando 1-12 de 12 artigos, teses e dissertações.
-
1. Non-motor symptoms fluctuations in patients with Parkinson's disease at the Clinical Hospital of Salvador, Bahia
RESUMO. A flutuação dos sintomas na doença de Parkinson é uma complicação frequente em longo prazo. Pouco é conhecido sobre a prevalência e a incidência de flutuações de sintomas não motores (SNM), principalmente na população brasileira. Objetivo: Verificar a frequência das flutuações dos SNM e sua relação com outros aspectos da doença d
Dementia & Neuropsychologia. Publicado em: 2022
-
2. Validação do questionário de 19 itens de wearing-off (WOQ-19) para a língua portuguesa
RESUMO Introdução: O tratamento da doença de Parkinson com terapia dopaminérgica melhora a funcionalidade e a qualidade de vida. Entretanto, com a progressão da doença, os fenômenos de flutuação motora e não motora se desenvolvem. Para melhorar o reconhecimento dessa situação, foi desenvolvido o questionário de 19 itens de wearing-off (WOQ-19)
Arq. Neuro-Psiquiatr.. Publicado em: 2020-10
-
3. Ground reaction forces during level ground walking with body weight unloading
Background: Partial body weight support (BWS) systems have been broadly used with treadmills as a strategy for gait training of individuals with gait impairments. Considering that we usually walk on level ground and that BWS is achieved by altering the load on the plantar surface of the foot, it would be important to investigate some ground reaction force (
Braz. J. Phys. Ther.. Publicado em: 09/01/2015
-
4. Especificidade e sensibilidade do Questionário Wearing-off 9-Itens em amostra brasileira de pacientes com doença de Parkinson
Objetivo (1) Verificar se o Questionário de Nove Itens (WOQ-9) para detectar wearing-off (WO) na doença de Parkinson (DP), pela sua capacidade de triagem, seria útil aos neurologistas na identificação de WO; (2) determinar a sensibilidade e especificidade da versão livre em Português Brasileiro do WOQ-9. Método Ao todo 60 indivíduos com DP compus
Arq. Neuro-Psiquiatr.. Publicado em: 2014-11
-
5. Complicações motoras e não motoras na levodopaterapia na doença de Parkinson / Motor and non-motor complications in levodopa therapy in Parkinson s
Study the motor and non-motor complications in a group of patients with Parkinson´s disease (PD) treated with levodopa (LD). Motor and non-motor complications were assessed in 61 patients (22 women and 39 men) with PD using LD. The Unified Parkinson s Disease Rating Scale (UPDRS), Hoehn &Yahr staging and Schwab &England ADL scale were used to assess the pat
IBICT - Instituto Brasileiro de Informação em Ciência e Tecnologia. Publicado em: 28/02/2012
-
6. Avaliação dos Níveis de Ansiedade em Pacientes com Doença de Parkinson em uso de Levodopa / Assessment of Anxiety Levels in Patients with Parkinson\ s disease using levodopa
A doença de Parkinson (DP) é uma patologia neurodegenerativa progressiva de causa desconhecida. A degeneração neuronal afeta vários grupos de neurônios no sistema nervoso central, mas de longe afeta muito mais os neurônios dopaminérgicos da pars compacta da substância nigra (SNc). Caracterizada por sintomas motores como bradicinesia, rigidez, tremor
IBICT - Instituto Brasileiro de Informação em Ciência e Tecnologia. Publicado em: 04/11/2011
-
7. Identificação de manifestações de wearing-off (redução do efeito da levodopa) em pacientes com doença de Parkinson utilizando questionário específico e comparação dos resultados com avaliações ambulatoriais de rotina
Este estudo teve como objetivo verificar se a presença do fenômeno wearing-off em pacientes com doença de Parkinson pode ser melhor identificada pela aplicação do cartão questionário wearing-off (QC). Os pacientes participantes foram avaliados pelos médicos residentes em neurologia e depois foram convidados a responder as questões do QC para detecç
Arquivos de Neuro-Psiquiatria. Publicado em: 2010-08
-
8. Current concepts in the diagnosis and management of Parkinson's disease
PARKINSON'S DISEASE IS A PROGRESSIVE NEUROLOGICAL disorder characterized by rest tremor, bradykinesia, rigidity and postural instability. The cause is unknown, but growing evidence suggests that it may be due to a combination of environmental and genetic factors. Treatment during the early stage of Parkinson's disease has evolved, and evidence suggests that
-
9. A randomised controlled study comparing bromocriptine to which levodopa was later added, with levodopa alone in previously untreated patients with Parkinson's disease: a five year follow up.
This pilot study was performed to compare the occurrence of long term motor complications in Parkinson's disease when the introduction of levodopa was delayed by an initial treatment with high doses of bromocriptine alone. The trial was a prospective randomised controlled study comparing 31 previously untreated patients with Parkinson's disease initially giv
-
10. Levodopa peripheral pharmacokinetics and duration of motor response in Parkinson's disease.
To assess the relative influence of central pharmacodynamic and peripheral pharmacokinetic factors on the duration of motor response to levodopa, the relationship between motor function and plasma levodopa levels was studied in 31 Parkinsonian patients. Duration of benefit from single levodopa doses while fasting depended on the degree to which the plasma le
-
11. Role of Sweat in Accumulation of Orally Administered Griseofulvin in Skin
Griseofulvin, an orally effective antimicrobial agent, appears in the stratum corneum within 4-8 h after oral administration. Griseofulvin distribution was found to be highest in the outermost layers of the stratum corneum (level I, 20.8±1.5 ng/mg) and lowest inside (level II, 10.0±1.5; level III, 7.5±2.2 ng/mg). In order to study the precise mechanism of
-
12. Children and bicycles: what is really happening? Studies of fatal and non-fatal bicycle injury.
OBJECTIVES: The objectives of the study were to ascertain the causes of accidents, injuries, and deaths in children who ride bicycles. Fatality and injury rates were also studied in order to compare with other studies. METHODS: Two studies of children were undertaken in children aged less than 15 years. In the first (retrospective fatality study), children w